-
81
TREMSUCS-TCGA – an integrated workflow for the identification of biomarkers for treatment success
Published 2024-12-01Get full text
Article -
82
Microneedle technology for enhanced topical treatment of skin infections
Published 2025-03-01Get full text
Article -
83
A symbiotic mosquito‐gut bacterium for flavivirus control
Published 2024-12-01Get full text
Article -
84
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
Published 2024-09-01Get full text
Article -
85
-
86
-
87
-
88
mTOR downregulation promotes anti-inflammatory responses via the CCL3-CCR5 axis in hypoxic retinopathy
Published 2025-03-01Get full text
Article -
89
Effect of Ranirestat, a New Aldose Reductase Inhibitor, on Diabetic Retinopathy in SDT Rats
Published 2014-01-01Get full text
Article -
90
-
91
-
92
-
93
Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
Published 2009-01-01“…This review discusses recently presented data from the ADNI dataset, and the importance of imaging in the future of drug development in AD.…”
Get full text
Article -
94
-
95
Synthesis and Antitubercular Evaluation of Diverse Glycosylated Ureas from D-Glucose
Published 2024-01-01“…Tripathi, Former Chief Scientist at CSIR-Central Drug Research Institute, Lucknow, India, for his extraordinary contribution to “Drug development against Tuberculosis”…”
Get full text
Article -
96
Toward <i>Mycobacterium tuberculosis</i> Virulence Inhibition: Beyond Cell Wall
Published 2024-12-01“…Although cell wall-associated targets are being actively studied for anti-TB drug development, other virulence factors important for adaptation and host interaction are also worth comprehensive analysis. …”
Get full text
Article -
97
Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology
Published 2014-01-01“…This review discusses the basic and clinical perspectives of angiogenesis highlighting the importance of comparative biology in understanding tumor angiogenesis and the integration of these model systems for future drug development.…”
Get full text
Article -
98
Antidiabetic Potential of Marine Brown Algae—a Mini Review
Published 2020-01-01“…Marine algae are an important source of bioactive metabolites in drug development and nutraceuticals. Diabetes mellitus is a metabolic disorder and the third leading cause of death worldwide due to lifestyle changes associated with rapid urbanization. …”
Get full text
Article -
99
Synthetic data as external control arms in scarce single-arm clinical trials.
Published 2025-01-01“…An external control arm based on health registry data can serve as an alternative comparator in single-arm drug development studies that lack a benchmark for comparison to the experimental treatment. …”
Get full text
Article -
100